MIX Office Hours

​You're building something innovative. But do you actually own it, and can you protect it?

​As AI becomes part of how MedTech companies develop products, new questions are emerging around intellectual property, patentability, and ownership. Whether you're building an AI-powered medical device or using AI tools to accelerate development, understanding how to protect your innovation is becoming increasingly important.

​Join Medical Innovation Exchange (MIX) and Greenberg Traurig for an interactive Office Hours session with Robert Ward, Partner at Greenberg Traurig, as we explore the intersection of AI, IP, and MedTech.

​What we'll discuss:

• ​AI & Patentability: Can you patent inventions developed with the help of AI?
• ​IP Ownership: Who owns what when AI tools are involved in product development?
• ​Protecting Your Innovation: What should MedTech startups prioritize when building their IP strategy?
• ​Investor Due Diligence: What do investors and potential acquirers look for when evaluating a startup's IP portfolio?
• ​Common IP Mistakes: What should founders avoid early on to prevent expensive problems later?

​Meet Our Expert

​Robert Ward | Partner, Greenberg Traurig

​Robert advises startups, venture capital firms, and global technology companies on intellectual property strategy, patents, and technology transactions. With over a decade of experience in artificial intelligence and an engineering background, he brings a practical perspective to protecting MedTech innovation.

​He has helped numerous medical device and AI startups build their IP strategies, navigate investor due diligence, and successfully exit.

​Come With Questions

​This isn't a traditional presentation. MIX Office Hours is designed for open conversation, practical insights, and direct access to experts who understand the challenges of building a MedTech company.

​Whether you're a founder, engineer, investor, or MedTech professional, bring your questions and join the discussion.